Uncertainty and Risk Concentration in Non-Traditional Protection Products
First written in FY2016. 2 of 6 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2020: 3 of 8 companies on the "Worse" side.
1 other company's latest entry also says "Other".
- FY2025Expansion to 6 protection products, including term medical insuranceAnnual report
「Furthermore, to date, we have limited our life insurance sales to protection products consisting of term life insurance, whole life medical insurance, term medical insurance, disability income insurance, cancer insurance and dementia insurance. As a result, the effect of diversifying risk in our risk portfolio may be relatively limited.」
The company explicitly included term medical insurance in its product lineup and continued to identify the limited risk diversification effect resulting from the focus on protection products. - FY2024Expansion to 6 protection productsAnnual report
「Furthermore, to date, we have limited our life insurance sales to protection products consisting of term life insurance, whole life medical insurance, disability income insurance, cancer insurance and dementia insurance. As a result, the effect of diversifying risk in our risk portfolio may be relatively limited.」
The addition of dementia insurance expanded the protection product lineup from the previous 5 products to 6, while the limited risk diversification effect resulting from the focus on protection products remains a risk. - FY2022RestatedAnnual report
「Furthermore, to date, we have limited our life insurance sales to protection products consisting of term life insurance, whole life medical insurance, disability income insurance, cancer insurance and dementia insurance. As a result, the effect of diversifying risk in our risk portfolio may be relatively limited.」
The company continues to describe a product lineup limited to 5 protection products, including cancer insurance, and the possibility that the effect of risk diversification may be relatively limited. - FY2018Expansion to 5 protection productsAnnual report
「Furthermore, to date, we have limited our life insurance sales to 5 protection products: term life insurance, whole life medical insurance, term medical insurance, disability income insurance and cancer insurance. As a result, the effect of diversifying risk in our risk portfolio may be relatively limited.」
The addition of cancer insurance increased the number of products from 4 to 5, but the limited diversification effect resulting from the focus on protection products remains a risk. - FY2017RestatedAnnual report
「To date, we have limited our life insurance sales to four protection products: term life insurance, whole life medical insurance, term medical insurance, and disability income insurance. As a result, the effect of diversifying risk in our risk portfolio may be relatively limited.」
The company continues to identify the limited effect of risk diversification resulting from a product lineup limited to 4 products and the uncertainty of incidence rates for nontraditional protection products. - FY2016First statedAnnual report
「To date, we have limited our life insurance sales to four protection products: term life insurance, whole life medical insurance, term medical insurance, and disability income insurance. As a result, the effect of diversifying risk in our risk portfolio may be relatively limited.」
The company identifies as a risk the limited effect of risk diversification resulting from offering only 4 products and the relative uncertainty of incidence rates for medical, illness and disability coverage.